Catecholamine-induced hyperuricemia in eviscerated rats with functional hepatectomy

Area of Science:

• Biochemistry
• Physiology
• Pharmacology

Background:

• The liver is traditionally considered the primary site of uric acid production.
• The role of extra-hepatic systems in uric acid metabolism, particularly under stress or stimulation, remains less understood.

Purpose of the Study:

• To investigate the existence and function of extra-hepatic systems in uric acid production.
• To determine the involvement of catecholamines and the sympathetic nervous system in inducing hyperuricemia via these extra-hepatic pathways.

Main Methods:

• Experiments were conducted on eviscerated rats with functional hepatectomy to isolate extra-hepatic contributions.
• Administration of catecholamines (isoproterenol, epinephrine, norepinephrine) and pharmacological agents (allopurinol, propranolol, phentolamine).
• Electrical stimulation of the splanchnic nerve and adrenalectomy were employed to assess neural and hormonal influences.

Main Results:

• Plasma uric acid levels increased in hepatectomized rats, indicating extra-hepatic production.
• Isoproterenol, epinephrine, and norepinephrine induced hyperuricemia, with isoproterenol being most potent.
• Beta-adrenergic blockade (propranolol) inhibited catecholamine-induced hyperuricemia, while alpha-blockade (phentolamine) had mixed effects.
• Splanchnic nerve stimulation and adrenalectomy affected hyperuricemia, suggesting sympathetic and adrenal involvement.
• Elevated plasma lactate, creatinine, and glutamic oxalacetic transaminase were observed with isoproterenol administration.

Conclusions:

• Beta-adrenergic agonists stimulate uric acid production in extra-hepatic tissues beyond the liver and viscera.
• Catecholamine-induced hyperuricemia involves beta-adrenoceptor activation in these extra-hepatic sites.
• The sympathetic nervous system and adrenal glands play a role in this extra-hepatic uric acid production pathway.